GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OKYO Pharma Ltd (LSE:OKYO) » Definitions » Total Long-Term Liabilities

OKYO Pharma (LSE:OKYO) Total Long-Term Liabilities : £0.00 Mil (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is OKYO Pharma Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. OKYO Pharma's Total Long-Term Liabilities for the quarter that ended in Mar. 2023 was £0.00 Mil.

OKYO Pharma Total Long-Term Liabilities Historical Data

The historical data trend for OKYO Pharma's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OKYO Pharma Total Long-Term Liabilities Chart

OKYO Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.02 0.05 - -

OKYO Pharma Semi-Annual Data
Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.03 - - -

OKYO Pharma Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

OKYO Pharma Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of OKYO Pharma's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

OKYO Pharma (LSE:OKYO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OKYO Pharma Ltd (LSE:OKYO) » Definitions » Total Long-Term Liabilities
Comparable Companies
TSBX INAB NKGN CGTX AVRO TLSA GDTC ANEB PASG MIST OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
OKYO:USA OK10:Germany
Address
14/15 Conduit St, Floor 4, London, GBR, W1S 2XJ
Website
https://www.okyopharma.com
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.